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Abstract 
Background: Revised international clinical guidelines for the antibiotic vancomycin have changed the advice phar-
macists need to provide to medical and nursing colleagues.
Objectives: (1) To determine the self-reported confidence of hospital pharmacists to provide contemporary advice 
on vancomycin and (2) to evaluate hospital pharmacists’ knowledge to provide contemporary advice on vancomycin 
following a pilot continuing professional development (CPD) module.
Methods: The study was a prospective two-phase design in an Australian teaching hospital. Phase one: a survey 
of pharmacist self-reported confidence to eight questions on providing contemporary advice on vancomycin. 
Responses were recorded using a Likert scales. Phase two: The provision of a pilot online CPD module on vancomycin 
containing knowledge-based assessment based on a clinical vignette. Likert scales recorded self-reported confi-
dence were reported as median and interquartile range (IQR). Knowledge assessment was reported using descriptive 
statistics. The main outcome measure were the self-reported confidence, and knowledge of pharmacists regarding 
provision of contemporary advice on clinical vancomycin use.
Results: Response rates for surveys; confidence n = 35 (72.9 %) and knowledge n = 31 (58.5 %). Phase one: con-
fidence was highest regarding vancomycin dosing and monitoring with 71.4–81.6 % of respondents agreeing or 
strongly agreeing that they were confident in these domains. Respondents agreeing or strongly agreeing were least 
confident regarding intravenous administration and infusion related reactions, 57.1 and 45.7 % respectively. Respond-
ents who provided advice on vancomycin >10 times in the prior 12 months reported significantly higher confidence 
in; therapeutic range 1 (IQR 1–2) versus 2 (IQR 1–3) p = 0.02; amending dosage based on therapeutic drug monitor-
ing results 2 (IQR 1–3) versus 3 (IQR 2–3) p = <0.001, and providing general advice to prescribers on vancomycin 
2 (IQR 1–3) versus 2 (IQR 2–4) p = <0.009. Knowledge questions were answered correctly post CPD by >75 % of 
pharmacists.
Conclusion: Pharmacists’ self-reported confidence to managing vancomycin was variable but generally high. Knowl-
edge scores were consistently high after pharmacists completed a pilot CPD module on vancomycin. These data 
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Background
Confidence and knowledge are important components 
for healthcare professionals’ ongoing competence to 
practice. Australian national law requires registered 
health practitioners to undertake continuing profes-
sional development (CPD) with the intention of ensuring 
knowledge is contemporary (Australian Health Practi-
tioners Regulation Agency 2014). Participating in CPD 
can meaningfully change knowledge, skills and attitudes 
of healthcare professionals (Cervero and Gaines 2015). 
Professional pharmacy organisations in Australian and 
internationally affirm the importance of maintaining cur-
rency of knowledge through CPD (International Phar-
maceutical Federation 2002; The Society of Hospital 
Pharmacists of Australia 2012; Pharmaceutical Society of 
Australia 2010; Driesen et al. 2007).
Vancomycin is an intravenous antibiotic used for nearly 
60  years in the treatment of Gram-positive infections 
and remains the therapy of choice for methicillin resist-
ant Staphylococcus aureus (MRSA) infection (Rybak et al. 
2013). While a small number of newer antibiotics to treat 
MRSA have been licenced by the United States Food and 
Drug Administration in recent years, it remains vital to 
reserve these agents for clinical situations when vanco-
mycin fails (Yu et al. 2014). In an era of increasing anti-
biotic resistance, necessitating higher therapeutic target 
concentrations and more aggressive dosing of vancomy-
cin (Lomaestro 2011), it is imperative to ensure the ability 
of pharmacists’ to confidently provide accurate contem-
porary advice to medical and nursing colleagues. This is 
important as there have been reported lack of confidence 
by pharmacists’ post evaluation of programs where phar-
macists are required to provide clinical and therapeutic 
advice, which has led pharmacists to call for more train-
ing (Rosenthal et al. 2010).
A North American consensus clinical practice guide-
line devised by medical and pharmacy experts and 
revised Australian guidelines on vancomycin have 
changed the nature of the advice pharmacists provide 
to medical and nursing staff (Rybak et al. 2009a; Antibi-
otic Expert Group 2010). Amongst a number of changes 
in these guidelines, doctors need to frequently prescribe 
loading doses and larger subsequent doses to achieve a 
higher serum therapeutic targets and be more cautious 
with monitoring (Rybak et  al. 2009b). Nursing staff are 
required to infuse vancomycin over revised durations 
of time to accommodate larger doses (Wilson and Estes 
2011; Karch 2012), while being more vigilant in observing 
for adverse effects, particularly infusion related reactions 
such as ‘red man syndrome’ (Hoelen et al. 2007).
Since these new recommendations for vancomycin 
have come into effect, it is unclear how confident phar-
macists are in recommending these changes to their 
professional colleagues. Furthermore, it is uncertain to 
what extent pharmacists’ confidence in their ability to 
provide contemporary advice is consistent with their 
actual knowledge of the revised recommendations for 
vancomycin.
The aims of this study were threefold. Firstly, to assess 
pharmacist baseline self-reported confidence in their 
ability to provide contemporary advice on vancomy-
cin. Secondly, to assess pharmacist knowledge scores 
after completion of an online vancomycin CPD module. 
Lastly, to explore any association between pharmacists 
self-reported confidence scores on providing vancomy-
cin management advice with actual assessed knowledge 
scores post-completion of a CPD module on vancomycin 
dosing and monitoring.
Methods
This pilot study was a prospective two phase design. The 
study was conducted at Flinders Medical Centre (FMC), a 
580-bed university teaching hospital located in Adelaide, 
South Australia. Study participants were identified from 
the register of pharmacists employed in the Division of 
Pharmacy at FMC.
The primary outcomes for the study were (1) to deter-
mine if the years of experience as a registered pharmacist 
have an effect on the self-reported confidence of phar-
macists to provide advice on the management of patients 
receiving vancomycin; and (2) if providing advice on 
vancomycin more than ten times in the prior 12 months 
resulted in greater pharmacist self-reported confidence 
to provide advice on vancomycin management. The sec-
ondary outcome was to report pharmacist knowledge 
scores following a structured online Continuing Profes-
sional Development (CPD) module on vancomycin dos-
ing and monitoring.
Phase one: confidence survey
In June 2012 all identified FMC pharmacists (n  =  48) 
were sent an email inviting them to participate in a 
provides impetus for a randomised controlled study across multiple sites to determine the extent to which pharma-
cist knowledge on vancomycin can be attributed to completion of an online CPD.
Keywords: Antibiotic, Confidence, Continuing education, Continuing professional development, Knowledge, 
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survey assessing their confidence in providing vancomy-
cin management advice. The survey was designed to cap-
ture self-reported confidence levels in providing advice 
on effective and safe management of patients receiving 
vancomycin. Questions were provided on core domains 
of pharmacists’ involvement in vancomycin manage-
ment; dosing, therapeutic drug monitoring and intra-
venous drug administration (see Additional file  1). The 
survey questions were structured as statements of confi-
dence on the various domains. The degree to which the 
pharmacists agreed or disagreed with each statement was 
recorded using a five-point Likert scale (Likert 1932). The 
following responses represent each point of the Likert 
scale: Strongly agree (1), agree (2), not sure (3), disagree 
(4) and strongly disagree (5). The phase one survey was 
hosted online by Survey Monkey, Portland, OR, USA 
(www.surveymonkey.net). No incentives were offered to 
complete the confidence survey.
Phase two: CPD and knowledge assessment
In February 2013, all identified FMC pharmacists 
(n  =  53) were emailed an invitation to undertake an 
electronic CPD on Vancomycin Dosing and Monitoring 
designed by local experts and opinion leaders from FMC. 
The email contained the CPD with questions (see Addi-
tional file 2), a copy of our institutions vancomycin clini-
cal practice guideline, and a link to assessable questions 
based on a practical clinical vignette which were also 
hosted on Survey Monkey.
The vancomycin CPD module had formal learning 
objectives; (1) to familiarise pharmacists with new insti-
tutional clinical practice guidelines on vancomycin dos-
ing and monitoring, secondly, (2) to understand the 
importance of the provision of appropriate and indi-
vidualised advice on vancomycin in clinical practice to 
medical and nursing colleagues, (3) to understand how 
to provide contemporary advice on vancomycin. The 
CPD module was endorsed by the Society of Hospital 
Pharmacists of Australia and the Australian Pharmacy 
Council for accreditation (number S2013/4) for 4 CPD 
credits. CPD credits accrue toward the Pharmacy Board 
of Australia’s mandatory requirement for compulsory 
ongoing professional development. Forty CPD credits are 
required annually to maintain registration in Australia 
(Pharmacy Board of Australia 2010). The opportunity 
to obtain CPD credits was the only incentive offered to 
undertake the CPD module and complete the assessable 
questions.
The CPD module contained background on vanco-
mycin regarding; the development of the vancomycin 
clinical practice guideline, efficacy, safety and reduced 
bacterial susceptibility to vancomycin along with phar-
maceutical formulations available from the state wide 
pharmacy service that supplies our local health network. 
Evidence-based, contemporary material was presented 
to cover all aspects of a pharmacists’ role in providing 
advice in the management of patients receiving van-
comycin. The CPD included a clinical vignette with ten 
assessable multiple choice questions, with only one cor-
rect answer from a choice of four answers. The ques-
tions covered similar domains to the confidence survey 
undertaken in phase one. Supplementary questions were 
asked of participants’ regarding the relevance of the CPD 
content and delivery mode (see Additional file  1. The 
study was granted full ethics approval from the South-
ern Adelaide Clinical Human Research Ethics Committee 
(approval number 123.12).
Statistical analysis and sample size
Data was analysed using the IBM Statistical Package 
for the Social Sciences (SPSS) version 22.0. Confidence 
scores recorded in a Likert scale were expressed as a 
median and IQR, and knowledge was reported using 
percentage of correctly answered responses for each 
question. Mann-Whitney U tests were used to compare 
median confidence scores where applicable with a p value 
of <0.05 considered statistically significant (Peacock and 
Peacock 2011). Required sample size was based on 80 % 
power to detect a mean difference of 0.5 in each Likert 
scale response between two groups, assuming a standard 
deviation of 0.55 for each Likert scale response, using a 
Mann Whitney U test for analysis and an underlying 
normal distribution of the responses. The means and 
medians for our data were all similar suggesting a normal 
distribution and the standard deviations ranged from 0.5 
to 1.0 for each question.
Results
Phase one: confidence survey
All 48 pharmacists employed in June 2012 in the Divi-
sion of Pharmacy were sent the confidence survey of 
which 35 completed (72.9  % response rate). There were 
22 (62.9  %) pharmacists with greater than 5  years of 
practice experience. (Table  1). From the 35 responding 
pharmacists, 51.4 % reported providing advice on vanco-
mycin to health professionals more than 10 times in the 
prior 12 months. The majority of respondents agreed or 
strongly agreed that they possessed confidence in pro-
viding advice on vancomycin to health professionals. 
Median confidence scores ranged from 2 (IQR 1–2) to 3 
(IQR 2–3) across the eight questions. Pharmacists’ self-
reported confidence was poorest in regards to provision 
of advice on vancomycin administration rates and the 
management of infusion related reaction. Pharmacists 
with less than 5  years of experience were significantly 
more confident in providing advice on the timing of first 
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vancomycin blood concentrations median score of 1 
(IQR 1–3) versus 2 (IQR 1–4) (p =  0.02); and knowing 
the therapeutic target range 1 (IQR 1–3) versus 2 (IQR 
1–3) (p = 0.04) compared to pharmacists with more than 
5  years of experience. The years of practice experience 
had no significant effect on the mean confidence scores 
for the remaining seven questions (Table 1).
The confidence of pharmacists with recent experience 
in providing vancomycin management advice, defined 
as providing advice greater than ten times in the past 
12 months is presented in Table 2. Pharmacists with more 
recent experience had significantly higher confidence in 
providing general advice on vancomycin to prescribers, 
median 2 (IQR 1–3) versus 2 (IQR 2–4) (p  =  <0.009). 
These pharmacists also reported a statistically significant 
greater awareness of the therapeutic target range, median 
1 (IQR 1–2) vs 2 (IQR 1-3) (p = 0.02), and confidence to 
amending vancomycin doses based on sub or supra-ther-
apeutic drug monitoring results compared to pharma-
cists with less experience, median 2 (IQR 1–3) versus 3 
(IQR 2–3) (p = <0.001) (Table 2).
Phase two: CPD and knowledge assessment
In February 2013, all FMC pharmacists (n  =  53) were 
invited to complete a structured CPD module on vanco-
mycin with knowledge assessment. A total of 31 pharma-
cists (58.5 % response rate) undertook the CPD module 
and completed the ten assessable questions. There were 
17 (54.8  %) pharmacists with greater than 5  years of 
practice experience. Some 22 (71 %) female participants 
Table 1 Hospital pharmacists’ mean self-reported confidence scores providing vancomycin management advice by years 
of practice experience
1 =  strongly agree, 2 = agree, 3 = not sure, 4 = disagree, 5 = strongly disagree
TDM therapeutic drug monitoring, IQR interquartile range, 1 Using Mann-Whitney
Confidence domains Median (IQR) confidence scores p value1
All respondents
n = 35
<5 years of experience
n = 13
>5 years of experience
n =  22
Therapeutic target range 2 (1–2) 1 (1–3) 2 (1–3) 0.04
Timing of first blood concentration 2 (1–2) 1 (1–3) 2 (1–4) 0.02
General advice to prescribers 2 (2–2) 2 (1–3) 2 (1–4) 0.32
Loading dose 2 (2–2) 2 (1–3) 2 (1–4) 0.13
Amending dosing based on TDM 2 (2–3) 2 (1–3) 2 (1–3) 0.10
Frequency of blood concentrations 2 (2–3) 2 (1–4) 2 (1–3) 0.83
Administration rate 2 (2–3) 3 (1–5) 2 (1–4) 0.13
Management of infusion related reactions 3 (2–3) 3 (1–5) 3 (1–5) 0.36
Table 2 Hospital pharmacists’ mean self-reported confidence scores on  providing vancomycin management advice 
by recent experience with vancomycin
1 =  strongly agree, 2 = agree, 3 = neutral, 4 = disagree, 5 = strongly disagree
TDM therapeutic drug monitoring, IQR interquartile range, 1Using Mann-Whitney
Confidence domains Median (IQR) confidence scores p 
value1
Provided advice <10 times in last 
12 months
n = 17
Provided advice >10 times in last 
12 months
n = 18
Therapeutic target range 2 (1–3) 1 (1–2) 0.02
Timing of first blood concentration 2 (1–4) 2 (1–3) 0.11
General advice to prescribers 2 (2–4) 2 (1–3) 0.009
Loading dose 2 (1–4) 2 (1–3) 0.10
Amending dosing based on TDM 3 (2–3) 2 (1–3) <0.001
Frequency of TDM 2 (1–3) 2 (1–4) 0.85
Administration rate 2 (1–4) 2 (1–5) 0.75
Management of infusion related reactions 3 (1–5) 2.5 (1–5) 0.63
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that completed the questions. Eight of the ten questions 
elicited correct responses ranging from 93.6–100  %. 
Questions regarding intravenous administration and 
management of adverse reactions were answered cor-
rectly with a relatively lower frequency of 77.4  % each 
(Table 3). All respondents agreed or strongly agreed that 
the CPD activity was of a high educational quality, well 
presented, up to date, worthwhile and achieved the stated 
learning objectives. All respondents agreed that the 
online CPD format suited them.
Confidence versus knowledge
Those pharmacists that self-reported 1 (strongly agree) 
or 2 (agree) on the Likert scale to questions about con-
fidence in phase one were considered confident. The 
responses from phase one were plotted against the 
knowledge scores attained in phase two. Percentage 
scores were higher for all domains post-completion of 
CPD as measured by knowledge scores (Fig. 1).
Discussion
This study sought baseline self-reported confidence of 
pharmacists to provide contemporary advice on vanco-
mycin clinical management to health professional col-
leagues in light of revised recommendations. In addition, 
this study set out to assess knowledge of vancomycin 
management after completion of a CPD on the topic. 
There are several strengths to this study. Firstly, the sur-
vey questions were designed to capture responses to key 
domains of vancomycin management reflected in expert 
consensus guidelines (Rybak et  al. 2009a). Secondly, the 
CPD was developed by local experts and opinion lead-
ers in clinical pharmacy, clinical pharmacology, infec-
tious diseases and clinical education, which is meaningful 
as a Cochrane review on the effect of local experts on 
professional practice found that local experts can suc-
cessfully influence evidence-based practice (Flodgren 
et  al. 2011). Lastly, the questions designed to assess 
Table 3 Hospital pharmacists’ knowledge scores for   
domains on  providing vancomycin management advice 
post continuing professional development
TDM therapeutic drug monitoring
Knowledge domain n (%)
Therapeutic target range 31 (100)
Timing to take first blood concentration (in renal impairment) 31 (100)
Frequency of blood concentration following dose stabilisation 30 (96.8)
Timing of blood concentration following dose adjustment 30 (96.8)
Amending dosing based on TDM 30 (96.8)
Subsequent maintenance dose 30 (96.8)
Loading dose 29 (93.6)
Timing of first blood concentration 29 (93.6)
Administration rate 24 (77.4)
Management of infusion related reaction 24 (77.4)
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Fig. 1 Percentage of hospital pharmacists who agreed or strongly agreed they were confident to provide advice on vancomycin and correct 
knowledge scores for the same domains post continuing professional development. TDM therapeutic drug monitoring
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pharmacist knowledge post CPD were derived from a 
clinical vignette with very practical every-day application 
to interprofessional advice directly affecting patient care. 
The use of clinical vignettes in online continuing educa-
tion has been associated with health professionals being 
more likely to make evidence-based decisions (Casebeer 
et al. 2010).
An overall response rate of more than fifty percent of 
the invited pharmacists was observed in both phases of 
the study. A number of online surveys of pharmacists 
related to CPD have attracted lower response rates than 
those obtained in this current study (Ang et  al. 2013; 
Power et al. 2011, 2008). Specifically the response rate of 
73  % obtained in phase one is more than that reported 
(67  %) by other authors examining pharmacist self-
reported confidence (Awaisu et  al. 2015). A response 
rate of 59  % was achieved in phase two which is also 
greater than that obtained (44 %) from another pharma-
cist knowledge assessment conducted post CPD in our 
department (Grzeskowiak et  al. 2015). While barriers 
have been reported to undertaking CPD online (Donyai 
et  al. 2011), this did not seem to be overly problematic 
for this CPD, with all respondents agreeing the online 
mode suited them. The only potential incentive to partic-
ipate was in phase two where CPD credits were available 
post-completion of the module. The department did not 
overly encourage pharmacist participation in the study. 
FMC Pharmacy Department has a view to encourage 
and support participation in CPD while acknowledging 
that ultimately it is the responsibility of the individual. 
Pharmacists must ensure they are competent and capa-
ble of discharging their duties as luminaries on pharmacy 
CPD have recently stated (Tofade et  al. 2015). Further, 
pharmacists should undertake CPD to meet educational 
needs for their scope of practice (McMahon 2015).
Overall, pharmacists reported greatest self-confidence 
in the domains of therapeutic drug monitoring, followed 
by dosing advice and least confident to providing advice 
on intravenous administration of vancomycin and man-
aging infusion related reactions. Interestingly there was 
no difference in self-reported confidence for those with 
less than 5  years’ experience except regarding when to 
draw the first blood sample to measure a vancomycin 
concentration. This is noteworthy as it has been reported 
that if patients have blood drawn too early in the treat-
ment (i.e. serum levels are not at stead-state concen-
tration), this can lead to medical staff misinterpreting 
concentrations and subsequently prescribing inappropri-
ate dosages (Morrison et al. 2012). What impacted most 
on pharmacist confidence was recent experience provid-
ing advice on vancomycin rather than their years of prac-
tice experience. Pharmacists that had provided advice 
on more than ten occasions in the prior year reported 
significantly more confidence regarding; provision of 
general advice on vancomycin to doctors, knowing the 
therapeutic target range and interpreting concentrations 
to amend dosage regimens.
After completion of the vancomycin CPD, more than 
three-quarters of pharmacists surveyed answered all 
knowledge questions correctly. A score in excess of 
ninety per cent was obtained for the majority of ques-
tions. These results compare similarly to those of other 
authors where a high knowledge score was attained post 
completion of a targeted continuing pharmacy education 
program. (Charpentier et al. 2012).
Questions about managing infusion-related problems 
and intravenous administration rates generated the low-
est self-reported confidence and knowledge scores. These 
findings are concerning as vancomycin features promi-
nently in medication errors made by nursing staff with 
intravenous administration errors rating highly (Hoefel 
et al. 2008; Fahimi et al. 2008). Further, the rate of admin-
istration of vancomycin infusion can directly precipitate 
an infusion related reaction such as red man syndrome 
(Lilley and Guanci 1995; Garrelts and Peterie 1985; Wal-
lace et  al. 1991; Sivagnanam and Deleu 2003; Bauters 
et  al. 2012). This finding suggests more can be done to 
ensure pharmacist competency in the provision of advice 
on administration rates and management of infusion-
related problems. While baseline confidence on a num-
ber of questions was high, a greater knowledge score 
was attained for all questions post CPD, which is likely 
to reflect favourably on the content and practical nature 
of the CPD as was confirmed in responses to supplemen-
tary questions.
The results of this study suggest that years of practice 
as a pharmacist do not routinely translate into higher 
confidence regarding provision of advice on vancomycin 
management. Based on these findings, completing a van-
comycin CPD module such as the one developed for this 
study may be of value to pharmacists irrespective of their 
years of experience if it is clinically relevant to their scope 
of practice.
Limitations
Considering potential limitations of this study. The con-
fidence survey in phase one and CPD in phase two were 
sent to the same departmental email distribution list, 
however due to workforce issues the absolute number 
of pharmacists employed varied between the phases of 
the study. Participants in each phase are thus not neces-
sarily the same individuals. The study was not a before 
and after design and was conducted in a single centre. 
However, as more than half the pharmacists employed 
in our institution participated in each phase of the study, 
the results are likely to be reflective of the wider cohort. 
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Lastly, selection bias may have been in effect in that those 
pharmacists who were more confident with contem-
porary practice or more amendable to improving their 
knowledge may have chosen to participate, while those 
in greatest need of updating their knowledge may have 
elected not to participate.
Conclusion
Pharmacists provide an important and valuable role 
assisting their medical and nursing colleague by provid-
ing contemporary guidance on medication management. 
Pharmacists’ ability to provide advice on revised recom-
mendations on vancomycin management is important to 
ensure the clinically safe and efficacious use of this essen-
tial antibiotic. This study adds to the literature on phar-
macists’ confidence and knowledge to provide clinical 
advice. Pharmacists self-reported a variable but gener-
ally high degree of confidence in the use of vancomycin. 
After completion of a pilot online CPD on vancomycin, 
pharmacists achieved consistently high scores in knowl-
edge assessment. Our results need to be interpreted with 
caution. A larger and randomised multi-centre study is 
required to determine if these findings are reproducible.
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